|
|
Norsk
versjon
In order to register data in Cristin, you must be an academic or administrative employee.
|
|
|
|
|
|
|
|
|
Showing results 1-16 of 16
|
|
2024
|
1. |
Raknes, Guttorm; Fagerås, Stephanie Jebsen; Sveen, Kari Anne; Juliusson, Pétur Benedikt; Strøm, Marianne Sørlie. Excess non-COVID-19 mortality in Norway 2020–2022. BMC Public Health 2024 ;Volume 24.(1) p. 1-13 UNN FHI UiB HAUKELAND
Untitled
|
2023
|
2. |
Strøm, Marianne Sørlie; Sveen, Kari Anne; Raknes, Guttorm; Slungård, Gunhild Forland; Fagerås, Stephanie Jebsen. Dødsårsaksregisteret. Dødsårsaker i Norge 2022. Oslo: Folkehelseinstituttet. Område for helsedata og digitalisering 2023 (ISBN 9788284063850) 50 p. FHI
Untitled
|
|
3. |
Knudsen, Ann Kristin Skrindo; Madsen, Christian; Forthun, Ingeborg; Tvedten, Hilde Marie; Dahl, Jesper; Lyngstad, Trude Marie; Strøm, Marianne Sørlie; Fagerås, Stephanie Jebsen; Tapia, German; Schwinger, Catherine; Aavitsland, Preben; Paulsen, Trine Hessevik; Kløvstad, Hilde; Baravelli, Carl; Sveen, Kari Anne; Zahl, Per Henrik; Juliusson, Pétur Benedikt; Gulseth, Hanne Løvdal. Dødelighet i Norge under koronapandemien 2020–2022. Folkehelseinstituttet 2023 (ISBN 9788284063843) 51 p. FHI
Untitled
|
|
4. |
Norhammar, Anna; Bodegard, Johan; Vanderheyden, Marc; Tangri, Navdeep; Karasik, Avraham; Maggioni, Aldo Pietro; Sveen, Kari Anne; Taveira-Gomes, Tiago; Botana, Manuel; Hunziker, Lukas; Thuresson, Marcus; Banerjee, Amitava; Sundström, Johan; Bollmann, Andreas. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. Heart 2023 p. 1-9 UiO OUS
Untitled
|
|
5. |
Sveen, Kari Anne; Fagerås, Stephanie Jebsen; Strøm, Marianne Sørlie; Lillesund, Berit. Dødsfall i Norge blant ikke-bosatte 2019. Oslo: Folkehelseinstituttet, Område for helsedata og digitalisering, Dødsårsaksregisteret 2023 (ISBN 978-82-8406-348-5) 15 p. HAUKELAND FHI
Untitled
|
|
6. |
Sveen, Kari Anne; Fagerås, Stephanie Jebsen; Strøm, Marianne Sørlie; Lillesund, Berit. Dødsfall i Norge blant ikke-bosatte 2020. Oslo: Folkehelseinstituttet, Område for helsedata og digitalisering, Dødsårsaksregisteret 2023 (ISBN 978-82-8406-349-2) 15 p. HAUKELAND FHI
Untitled
|
2021
|
7. |
Sveen, Kari Anne; Holte, Kristine Bech; Svanteson, Mona; Hanssen, Kristian F.; Nilsson, Jan-Åke; Bengtsson, Eva; Berg, Tore Julsrud. Autoantibodies against methylglyoxal-modified apolipoprotein B100 and apob100 peptide are associated with less coronary artery atherosclerosis and retinopathy in long-term type 1 diabetes. Diabetes Care 2021 ;Volume 44.(6) p. 1402-1409 OUS UiO
Untitled
|
|
8. |
Sveen, Kari Anne; Smith, Gustav; Björkbacka, Harry; Orho-Melander, Marju; Engström, Gunnar; Gonçalves, Isabel; Melander, Olle; Nilsson, Jan; Bengtsson, Eva. High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women. Journal of Internal Medicine 2021 ;Volume 291.(2) p. 207-217 OUS
Untitled
|
2020
|
9. |
Holte, Kristine Bech; Svanteson, Mona; Hanssen, Kristian Folkvord; Sveen, Kari Anne; Seljeflot, Ingebjørg; Solheim, Svein; Sell, D R; Monnier, VM; Berg, Tore Julsrud. Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study. PLOS ONE 2020 UiO OUS
Untitled
|
2015
|
10. |
Sveen, Kari Anne; Dahl-Jørgensen, Knut; STENSÆTH, KNUT-HAAKON; Angel, Kristin; Seljeflot, Ingebjørg; Sell, David R; Monnier, Vincent M; Hanssen, Kristian Folkvord. Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes. Journal of Diabetes and its Complications (JDC) 2015 ;Volume 29.(3) p. 407-412 UiO OUS
Untitled
|
2014
|
11. |
Sveen, Kari Anne; Nerdrum, Tone; Hanssen, Kristian Folkvord; Brekke, Magne; Torjesen, Peter A; Strauch, Christopher M; Sell, David R; Monnier, Vincent M; Dahl-Jørgensen, Knut; Steine, Kjetil. Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: Associations with protein glycation. Diabetes & vascular disease research 2014 ;Volume 11.(2) p. 84-91 UiO OUS AHUS
Untitled
|
2013
|
12. |
Sveen, Kari Anne; Karimé, Bassam; Jørum, Ellen; Mellgren, Svein Ivar; Fagerland, Morten; Monnier, Vincent; Dahl-Jørgensen, Knut; Hanssen, Kristian Folkvord. Small- and large-fiber neuropathy after 40 years of type 1 diabetes associations with glycemic control and advanced protein glycation: the Oslo Study. Diabetes Care 2013 ;Volume 36.(11) p. 3712-3717 OUS UiO UiT
Untitled
|
|
13. |
Sveen, Kari Anne; Ørstavik, Kristin; Fosmark, Dag Sigurd; Dahl-Jørgensen, Knut; Hanssen, Kristian Folkvord. Retinal nerve fibre layer thickness is associated with measures of small fibre neuropathy in long-term type 1 diabetes. Diabetologia 2013 ;Volume 56. p. S499-S500 OUS
Untitled
|
2012
|
14. |
Fraser, David; Diep, Lien My; Hynås, Inger Anette; Nilsen, Kristian Bernhard; Sveen, Kari Anne; Seljeflot, Ingebjørg; Hanssen, Kristian Folkvord. Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097. Diabetes Care 2012 ;Volume 35.(11) p. E80-E80 OUS NTNU UiO
Untitled
|
|
15. |
Fraser, David; Diep, Lien My; Hynås, Inger Anette; Nilsen, Kristian Bernhard; Sveen, Kari Anne; Seljeflot, Ingebjørg; Hanssen, Kristian Folkvord. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes A 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care 2012 ;Volume 35.(5) p. 1095-1097 OUS NTNU UiO
Untitled
|
|
16. |
Fraser, David; Diep, Lien My; Hynås, Inger Anette; Nilsen, Kristian Bernhard; Sveen, Kari Anne; Seljeflot, Ingebjørg; Hanssen, Kristian Folkvord. The effects of oral benfotiamine on peripheral nerve function and inflammatory markers in type-1 diabetes: a 24-month, double-blind, randomised, placebo-controlled trial. European Journal of Neurology 2012 ;Volume 19. p. 416-416 OUS NTNU UiO
Untitled
|
|